Mylan offers discounts on EpiPen amid wave of criticism
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Valeant Pharma (VRX) Shares Move Higher Early
August 25, 2016 9:37 AM EDTValeant Pharma (NYSE: VRX) shares are ticking higher early. The stock is up over 2 percent with strong volume.
... MoreMylan (MYL) Gains Early After Taking Action on EpiPen Pricing
August 25, 2016 7:51 AM EDTAfter dropping sharply over the past few sessions on headline risk related to EpiPen pricing, Mylan (NASDAQ: MYL) shares are gaining 3% early after the company announced plans to reduce patient cost through savings card which will cover up to $300 for their EpiPen 2-Pak.
... More